Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318306-08-000027
Filing Date
2008-05-20
Accepted
2008-05-20 17:04:25
Documents
6
Period of Report
2008-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 10Q a10q-033108.htm 10-Q 435209
2 AMENDMENT TO DAVIS EMPLOYMENT AGREEMENT ex_10-30.htm EX-10.30 16927
3 CEO CERTIFICATION ex_31-1.htm EX-31.1 16895
4 CFO CERTIFICATION ex_31-2.htm EX-31.2 17288
5 CEO CERTIFICATION ex_32-1.htm EX-32.1 5967
6 CFO CERTIFICATION ex_32-2.htm EX-32.2 5755
  Complete submission text file 0000318306-08-000027.txt   499660
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 08849430
SIC: 2834 Pharmaceutical Preparations